Aldosterone Receptor Antagonists [phsu]
Cardiovascular disease [dsyn]
Review [inpr]
Recent [tmco]
Literature [inpr]
Insight [menp]
Potential [qlco]
Future [tmco]
Indications [idcn]
randomized controlled trials [inpr, resa]
Efficacy [qlco]
Aldosterone Receptor Antagonists [phsu]
Spironolactone [phsu, strd]
eplerenone [phsu, strd]
Pharmacologic [bmod]
intervention [hlca]
Patients [podg]
New York Heart Association Class III [fndg]
Heart failure [dsyn]
Patients [podg]
ejection fraction [diap]
Myocardial Infarction [dsyn]
Most [qnco]
Recently [tmco]
Patients [podg]
MILDLY [idcn]
Symptomatic [ftcn]
Heart failure [dsyn]
Aldosterone Receptor Antagonists [phsu]
Broad [spco]
Population [qnco]
Aldosterone Receptor Antagonists [phsu]
Anti-arrhythmic Agent [phsu]
Pharmacologic [bmod]
Atrial [bpoc]
Ventricular arrhythmias [patf]
Ischaemic [ftcn]
Medication [phsu]
coronary artery disease [dsyn]
Prevention [topp]
Myocardial fibrosis [patf]
vascular [bpoc]
Damage [inpo]
Agent [chvf]
People [popg]
Asymptomatic [fndg]
Mild [qlco]
Heart failure [dsyn]
New York Heart Association Class I [fndg]
Heart Failure, Diastolic [dsyn]
clinicians [prog]
Reluctant [menp]
Highly [qlco]
Efficacy [qlco]
pharmacologic therapy [ftcn]
Variety [cnce]
reasons [idcn]
Including [ftcn]
Concerns [idcn]
Polypharmacy [fndg]
Hyperkalaemia [fndg]
Recent [tmco]
OBSERVATIONAL [resa]
Analysis [lbpr]
One [qnco]
Third [qnco]
eligible [idcn]
Patients [podg]
hospitalized [fndg]
Heart failure [dsyn]
Received [qlco]
Aldosterone antagonist [phsu]
therapy [ftcn]
This [euka]
Article [inpr]
Review [inpr]
Current [tmco]
Potential [qlco]
Future [tmco]
Aldosterone Receptor Antagonists [phsu]
Entire [qnco]
Spectrum [qnco]
Cardiovascular disease [dsyn]
Authors [prog]
Funding [qnco]
financial [qnco]
Relationships [qlco]
Conflict of Interest [idcn]
